Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Sangeeta Dhami; Ulugbek Nurmatov; Giovanni Battista Pajno; Montserrat Fernandez-rivas; Antonella Muraro; Graham Roberts; Cezmi Akdis; Montserrat Alvaro-lozano; Kirsten Beyer; Carsten Bindslev-jensen; Wesley Burks; George Du Toit; Motohiro Ebisawa; Philippe Eigenmann; Edward Knol; Mika Makela; Kari Christine Nadeau; Liam O’mahony; Nikolaos Papadopoulos; Lars Poulsen; Cansin Sackesen; Hugh Sampson; Alexandra Santos; Ronald Van Ree; Frans Timmermans; Aziz Sheikh

doi:10.1186/s13601-016-0113-z

Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Sangeeta Dhami, Ulugbek Nurmatov, Giovanni Battista Pajno, Montserrat Fernandez-rivas, Antonella Muraro, Graham Roberts, Cezmi Akdis, Montserrat Alvaro-lozano, Kirsten Beyer, Carsten Bindslev-jensen, Wesley Burks, George Du Toit, Motohiro Ebisawa, Philippe Eigenmann, Edward Knol, Mika Makela, Kari Christine Nadeau, Liam O’mahony, Nikolaos Papadopoulos, Lars PoulsenCansin Sackesen, Hugh Sampson, Alexandra Santos, Ronald Van Ree, Frans Timmermans, Aziz Sheikh

King's College London

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

171 Downloads (Pure)

Abstract

Background

The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.

Methods

We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.

Discussion

The findings from this review will be used to inform the development of recommendations for EAACI’s Guidelines on AIT.

Original language	English
Journal	Clinical and translational allergy
Volume	6
Issue number	1
DOIs	https://doi.org/10.1186/s13601-016-0113-z
Publication status	Published - 5 Jul 2016

Access to Document

10.1186/s13601-016-0113-zLicence: CC BY

Allergen immunotherapy for_DHAMI_Accepted 17May2016_GOLD VoR
© 2016 Dhami et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Final published version, 798 KBLicence: CC BY

Cite this

Dhami, S., Nurmatov, U., Pajno, G. B., Fernandez-rivas, M., Muraro, A., Roberts, G., Akdis, C., Alvaro-lozano, M., Beyer, K., Bindslev-jensen, C., Burks, W., Du Toit, G., Ebisawa, M., Eigenmann, P., Knol, E., Makela, M., Nadeau, K. C., O’mahony, L., Papadopoulos, N., ... Sheikh, A. (2016). Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review. Clinical and translational allergy, 6(1). https://doi.org/10.1186/s13601-016-0113-z

@article{a6429ff59f634acca6f02e38e98c08b4,

title = "Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review",

abstract = "BackgroundThe European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.MethodsWe will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DiscussionThe findings from this review will be used to inform the development of recommendations for EAACI{\textquoteright}s Guidelines on AIT.",

author = "Sangeeta Dhami and Ulugbek Nurmatov and Pajno, {Giovanni Battista} and Montserrat Fernandez-rivas and Antonella Muraro and Graham Roberts and Cezmi Akdis and Montserrat Alvaro-lozano and Kirsten Beyer and Carsten Bindslev-jensen and Wesley Burks and {Du Toit}, George and Motohiro Ebisawa and Philippe Eigenmann and Edward Knol and Mika Makela and Nadeau, {Kari Christine} and Liam O{\textquoteright}mahony and Nikolaos Papadopoulos and Lars Poulsen and Cansin Sackesen and Hugh Sampson and Alexandra Santos and {Van Ree}, Ronald and Frans Timmermans and Aziz Sheikh",

year = "2016",

month = jul,

day = "5",

doi = "10.1186/s13601-016-0113-z",

language = "English",

volume = "6",

journal = "Clinical and translational allergy",

issn = "2045-7022",

publisher = "BioMed Central",

number = "1",

}

Dhami, S, Nurmatov, U, Pajno, GB, Fernandez-rivas, M, Muraro, A, Roberts, G, Akdis, C, Alvaro-lozano, M, Beyer, K, Bindslev-jensen, C, Burks, W, Du Toit, G, Ebisawa, M, Eigenmann, P, Knol, E, Makela, M, Nadeau, KC, O’mahony, L, Papadopoulos, N, Poulsen, L, Sackesen, C, Sampson, H, Santos, A, Van Ree, R, Timmermans, F & Sheikh, A 2016, 'Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review', Clinical and translational allergy, vol. 6, no. 1. https://doi.org/10.1186/s13601-016-0113-z

TY - JOUR

T1 - Allergen immunotherapy for IgE-mediated food allergy

T2 - protocol for a systematic review

AU - Dhami, Sangeeta

AU - Nurmatov, Ulugbek

AU - Pajno, Giovanni Battista

AU - Fernandez-rivas, Montserrat

AU - Muraro, Antonella

AU - Roberts, Graham

AU - Akdis, Cezmi

AU - Alvaro-lozano, Montserrat

AU - Beyer, Kirsten

AU - Bindslev-jensen, Carsten

AU - Burks, Wesley

AU - Du Toit, George

AU - Ebisawa, Motohiro

AU - Eigenmann, Philippe

AU - Knol, Edward

AU - Makela, Mika

AU - Nadeau, Kari Christine

AU - O’mahony, Liam

AU - Papadopoulos, Nikolaos

AU - Poulsen, Lars

AU - Sackesen, Cansin

AU - Sampson, Hugh

AU - Santos, Alexandra

AU - Van Ree, Ronald

AU - Timmermans, Frans

AU - Sheikh, Aziz

PY - 2016/7/5

Y1 - 2016/7/5

N2 - BackgroundThe European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.MethodsWe will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DiscussionThe findings from this review will be used to inform the development of recommendations for EAACI’s Guidelines on AIT.

AB - BackgroundThe European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.MethodsWe will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DiscussionThe findings from this review will be used to inform the development of recommendations for EAACI’s Guidelines on AIT.

U2 - 10.1186/s13601-016-0113-z

DO - 10.1186/s13601-016-0113-z

M3 - Article

SN - 2045-7022

VL - 6

JO - Clinical and translational allergy

JF - Clinical and translational allergy

IS - 1

ER -

Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Abstract

Access to Document

Fingerprint

Cite this